Goldman Sachs Maintains Buy on Doximity, Lowers Price Target to $56
Goldman Sachs maintains Doximity (NYSE:DOCS) with a Buy and lowers the price target from $72 to $56.
Peering Into Doximity’s Recent Short Interest
Doximity's (NYSE:DOCS) short percent of float has risen 3.27% since its last report. The company recently reported that it has 7.21 million shares sold short, which is 8.22% of all regular shares that are available for trading.
14 Stocks Moved By Traders on ‘Fast Money: Halftime Report’
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.
Guggenheim Maintains Buy on Doximity, Lowers Price Target to $52
Guggenheim analyst Sandy Draper maintains Doximity (NYSE:DOCS) with a Buy and lowers the price target from $70 to $52.
Raymond James Maintains Outperform on Doximity, Lowers Price Target to $40
Raymond James analyst Brian Peterson maintains Doximity (NYSE:DOCS) with a Outperform and lowers the price target from $60 to $40.
Baird Maintains Outperform on Doximity, Lowers Price Target to $45
Baird analyst Vikram Kesavabhotla maintains Doximity (NYSE:DOCS) with a Outperform and lowers the price target from $68 to $45.
Needham Maintains Buy on Doximity, Lowers Price Target to $45
Needham analyst Scott Berg maintains Doximity (NYSE:DOCS) with a Buy and lowers the price target from $70 to $45.
20 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Decisionpoint Systems, Inc. (NASDAQ: DPSI) rose 47.2% to $7.02 in pre-market trading after jumping around 19% on Tuesday. DecisionPoint Systems recently reported first-quarter FY22 revenue growth of 22.7% year-on-year to $19.7 million.
SVB Leerink Maintains Outperform on Doximity, Lowers Price Target to $67
SVB Leerink analyst Stephanie Davis maintains Doximity (NYSE:DOCS) with a Outperform and lowers the price target from $72 to $67.
